Related Experiment Videos
Risperidone in idiopathic and symptomatic dystonia: preliminary experience
E Grassi1, S Latorraca, S Piacentini
1Department of Neurological and Psychiatric Sciences, University of Florence, Italy.
Summary
Risperidone effectively reduced involuntary movements and abnormal postures in patients with dystonia. This study shows significant improvement in symptoms after four weeks of treatment.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Dystonia is a movement disorder characterized by involuntary muscle contractions causing abnormal postures.
- Idiopathic and symptomatic dystonias present significant challenges in treatment.
- Risperidone, a neuroleptic, exhibits antiserotoninergic (5HT2) and antidopaminergic (D2) properties.
Observation:
- A study investigated the efficacy of risperidone in seven patients diagnosed with idiopathic or symptomatic dystonia.
- Patients received daily doses of risperidone ranging from 2 to 6 mg for four weeks.
- The Fahn and Marsden rating scale was used to assess the severity of torsion dystonia before and after treatment.
Findings:
- All seven patients experienced a reduction in twisting and involuntary movements.
- Abnormal postures associated with dystonia also decreased following risperidone treatment.
- A statistically significant mean improvement of 41% was observed (p = 0.009, CI 95%).
Implications:
- Risperidone demonstrates potential as a therapeutic agent for managing dystonia.
- The findings suggest risperidone's utility in both idiopathic and symptomatic forms of the disorder.
- Further research may explore risperidone's long-term efficacy and optimal dosing for dystonia treatment.